Privately held Carticept Medical won FDA clearance for the next generation of its Navigator delivery system, which the company touts as the 1st and only computer-controlled injections system on the U.S. market. The enhanced Navigator includes new software features designed to "improve further office and work-flow efficiency," according to the company.
BD Medical, a segment of BD, a leading global medical technology company, announced today the commercial launch of a new passive needle guard technology, BD UltraSafe PLUS™. The BD UltraSafe PLUS™ Passive Needle Guard has received 510(k) clearance as an anti-needlestick safety device.
Scientists described key advances toward practical uses of a new genre of tiny, biocompatible electronic devices that could be implanted into the body to relieve pain or battle infection for a specific period of time, and then dissolve harmlessly.
Placement of copper objects in intensive care unit (ICU) hospital rooms reduced the number of healthcare-acquired infections (HAIs) in patients by more than half, according to a new study published in the May issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, in a special topic issue focused on the role of the environment in infection prevention.
AdvaMed 2013 is the leading MedTech conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking.
As demonstrated in these videos, sitting at rest, the adaptive and multifunctional material is smooth, clear and flat; droplets of water or oil on its omniphobic surface flow freely down its surface. Stretching or bending it makes the fluid surface rougher. The rough surface is opaque, and also confers the ability to precisely control the movement of water or oil droplets.
A new separation process that depends on an easily-distinguished physical difference in adhesive forces among cells could help expand production of stem cells generated through cell reprogramming. By facilitating new research, the separation process could also lead to improvements in the reprogramming technique itself and help scientists model certain disease processes.
Imagine a tent that blocks light on a dry and sunny day, and becomes transparent and water-repellent on a dim, rainy day. Or highly precise, self-adjusting contact lenses that also clean themselves. Or pipelines that can optimize the rate of flow depending on the volume of fluid coming through them and the environmental conditions outside.
NxStage® Medical a leading manufacturer of innovative dialysis products, announced today that it has completed its move to a direct sales model in the United Kingdom. NxStage will begin selling the System One™ and related products and services directly in the region through its wholly-owned UK subsidiary, NxStage Medical UK.
The FDA put its highest-risk category on Johnson & Johnson subsidiary Animas Corp.'s insulin pump recall over concerns that the devices may cause patient harm or even death. Certain pumps were recalled over concerns that a "component" issue could trigger a false alarm or a sudden warning requiring that the patient rewind, load and prime the device.
Animas has identified a component issue affecting Animas(R) 2020 Infusion Insulin Pumps manufactured from March 1, 2012 to November 30, 2012. The component issue may trigger the pumps to sound a false alarm or warning related to one of the following...
Watertown, Mass.-based pSivida and its licensee Alimera Sciences submitted a new response to the FDA in hopes of highlighting the safety profile of the Iluvien chronic diabetic macular edema treatment, a drug-device combination that the federal watchdog agency rejected in November 2011.
If biologists could put computational controls inside living cells, they could program them to sense and report on the presence of cancer, create drugs on site as they’re needed, or dynamically adjust their activities in fermentation tanks used to make drugs and other chemicals. Now researchers at Stanford University have developed a way to make genetic parts that can perform the logic calculations that might someday control such activities.
It's been a rocky road for pSivida's Illuvien, a drug/device combination for diabetic macular edema, but the company hopes that new trial data will pave the way to regulatory approval in the U.S. Watertown, Mass.-based pSivida, which licenses the Iluvien technology to Alimera Sciences, said the two companies plan to re-submit a new drug application to the FDA by the end of this month.
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the first drug to be offered in the just-launched BD SimplistT ready-to-administer, line of prefilled generic injectables....
Have you ever thrown into the fire - even if you shouldn't have - an empty packet of crisps? The outcome is striking: the plastic shrivels and bends into itself, until it turns into a small crumpled and blackened ball. This phenomenon is explained by the tendency of materials to pick up their original features in the presence of the right stimulus.
HONG KONG , March 22, 2013 /- Johnson Electric today announced a miniature medication dosing system technology under the Johnson Medtech brand. The subsystem platform provides a high precision dosing accuracy over device operational life. The Johnson Medtech system design delivers dosing forces up to 100N for various medication viscosities within a compact package.
Alcyone Lifesciences and DNAtrix, Inc. to Collaborate on Unique Delivery System to Treat Brain TumorsMarch 20, 2013 2:33 pm | by The Associated Press | News | Comments
Alcyone Lifesciences, Inc., a privately held biopharmaceutical medical device company focusing on developing products for the treatment of difficult neuropathological conditions, and DNAtrix, Inc., a privately held biotechnology company developing virus-based immunotherapy...
Fresenius said today that an FDA warning letter sent to its North American division isn't likely to have an impact on its sales and earnings guidance for this year. The German dialysis giant said the U.S. watchdog agency warned it about problems with its design verification and validation procedures at a plant in Ogden, Utah.
SAN JOSE, Calif. and SWANSEA, Wales, March 12, 2013 /PRNewswire/ -- Cellnovo, developer of the first mobile diabetes management system, and Flextronics (NASDAQ: FLEX), today announced that the two companies have entered into an agreement whereby Flextronics will manufacture and provide...
OTTAWA, March 8, 2013 /CNW/ - Health Canada is informing Canadians and Canadian health care practitioners that Hospira Inc., a drug and medical device manufacturer, is voluntarily stopping all new sales of its intravenous infusion pumps while it addresses issues in its quality...
New U.S. Market Data Shows ICU Medical's Needlefree IV Connector Technology Chosen More than Twice as Often as Any OtherMarch 7, 2013 8:00 am | by PR Newswire | News | Comments
SAN CLEMENTE, Calif., March 7, 2013 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ:ICUI) today announced that its family of needlefree intravenous (IV) connectors was chosen by U.S. healthcare providers more than twice as often as any other connector technology according to newly released...
Surefire Medical 's new infusion system maximizes delivery of drugs directly to the tumor site while minimizing potential damage to non-target organs, according to a new study . The ability to more safely and efficiently deliver embolic agents to target tumors locally marks a significant advance in radiation oncology procedures a...
LAKE FOREST, Ill. , March 1, 2013 /- Hospira, Inc. (NYSE: HSP) , the world's leading provider of injectable drugs and infusion technologies, today announced that Royce R. Bedward has been appointed corporate vice president, general counsel and secretary, effective immediately. In his new role, Mr. Bedward will oversee the company's legal department, including litigation...
As the utilization of MEMS continues to grow across various industry sectors, commercial successes like the use of STMicroelectronics’ PCR chips in drug delivery; Boehringer Ingelheim’s success with MEMS-based inhalers; and the microfluidic chips used in Abbott’s blood gas analyzers are helping to drive a growing demand for MEMS devices in the medical market.